Drug Research
Chiesi Global Rare Diseases Announces FDA Approval of Lamzede for Alpha-Mannosidosis
Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced that the U.S. FDA has approved Lamzede® (velmanase alfa-tycv) for the treatment of non-central nervous system manifestations of alpha-mannosidosis (AM)...
Drug Research
Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, announced a strategic research and development collaboration to discover and develop...
Drug Research
Predictive Oncology, Cvergenx Partner on Genomics-based AI Approach to Personalized Radiotherapy
Predictive Oncology Inc., will collaborate with CvergenX, Inc., on the first-ever genomics-based artificial intelligence approach to personalized radiotherapy and drug discovery.
The objective of this collaboration is to leverage and maximize the combined power of their respective proprietary technologies and...
Drug Research
CBM, Virion Partner on CD8+T cell-based Clinical Development Programs
Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, and Virion Therapeutics (Virion), a clinical-stage biotech company focused on the development of...
Drug Research
South Australia Government Looks To Boost Biomanufacturing
Biomanufacturing industry is all set to get the much-needed push by the recent South Australian Government’s announcement when it comes to new initiatives as far as training and development of next generation researchers in this field are concerned.
This will...
Drug Research
Oligonucleotide Drugs To Witness Novel Sterilisation Process
There is a new report which has gone on to review the processing of the present state of sterile oligonucleotide drug product. This includes recommendations to help in the evaluation and development of the terminal sterilisation processes, as well...
Drug Research
Foetal Development Protein Can Aid Acute Leukaemia Aversion
A protein present in foetal development has been zeroed upon by the researchers that has a strong prophylactic effect versus acute myeloid leukaemia- AML.
Right during the foetal pregnancy stage, numerous vital cell programmes become active in the foetal development....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read